The increasing prevalence of chronic diseases and the introduction of novel CT scan devices are contributing to the growth of the global computed tomography (CT) scanners market

calendar_today 04 October, 2022 person_outline Growth Plus Reports

According to the deep-dive market assessment study by Growth+ Reports, the global computed tomography (CT) scanners market reached ~US$ 5.9 billion in 2021. The market is expected to witness a CAGR of ~5.1% from 2022 to 2030. The global computed tomography (CT) scanners market is mainly driven by the rising geriatric population, increasing accident-associated trauma, and growing demand for high-precision imaging diagnostics. Moreover, the increasing prevalence of orthopedic, cardiovascular diseases and cancer is fueling the growth of global computed tomography (CT) scanners. However, expensive machines and equipment, high maintenance costs, and limited adoption rate for novel and innovative products due to high prices are holding the growth of the global computed tomography market.

The global computed tomography (CT) scanner market is divided into four categories: high-slice, mid-slice, low-slice, and cone beam computed tomography. Slices are cross-sections of a body part. Many clinics, radiology departments, and imaging diagnostics centers prefer low-slice computed tomography (CT) scanners that range from 8 to 32 slices. Because of their low cost, low maintenance, high demand for low slice computed tomography (CT) scanners in emerging countries, and strong product portfolio, low-slice computed tomography (CT) scanners hold the largest share of the global computed tomography (CT) scanners market. 

Computed tomography (CT) scanners are used to find and diagnose injuries from trauma, determine the location and size of a tumor, determine cancer stages, diagnose infections, detect the location of blood clots, diagnose conditions of the lungs and heart, and identify vague abdominal problems. According to the National Cancer Institute, in the United States, nearly 1,806,590 new cancer cases were reported, with 606,520 people dying from cancer in 2020. Breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, and bladder cancer were the most common cancers.  Prostate, lung, and colorectal cancers accounted for 43 percent of all cancers diagnosed in men in 2020. Breast, lung, and colorectal cancers were women's three most common cancers, accounting for an estimated 50% of all new cancer diagnoses in 2020.

Heart disease is the leading cause of death in the United States for men, women, and people of most racial and ethnic groups. According to the Centers for Disease Control and Prevention, in 2020, approximately 697,000 people in the United States will die from heart disease. From 2017 to 2018, the United States spent about US$ 229 billion on heart disease medications and healthcare services and lost productivity because of death. The most common type of heart disease is coronary heart/artery disease; nearly 382,820 people died in 2020. Coronary artery diseases affect approximately 20.1 million adults aged 20 and up (about 7.2 percent). In 2020, about two out of every ten deaths occurred from coronary heart disease in the United States. The increasing prevalence of cardiovascular diseases is helping the global computed tomography (CT) scanners market owing to the imperative need for precise cardiac diagnosis. CT angiograms have 91% accuracy in detecting artery blockages.

CT scanners are handy to most healthcare providers because of their ability to capture high-resolution inside images of the body. CT scanner slices usually take cross-sectional images of the body part. Low slice scanners range between 8 pieces to 32 portions. They are generally preferred by the radiology department, imaging diagnostics centers, and small clinics. Low slice computed tomography (CT) scanners lead the global computed tomography (CT) scanners market owing to their low cost, low maintenance and increasing demand in emerging countries, and strong product portfolio. Also, technological advancement and growing preference by diagnostic imaging centers contribute to the growth of low slice computed tomography (CT) scanners.

North America led the global market for computed tomography (CT) scanners, followed by the Asia Pacific. North America's dominance can be attributed to the high adoption of technological developments, advanced infrastructure, and high investment in healthcare systems. Asia Pacific is expected to show exponential growth in the computed tomography (CT) scanners market owing to its vast population, increasing prevalence of chronic diseases, increasing cancer cases, rapidly developing healthcare infrastructure, and improving healthcare expenditure.

Some of the prominent players operating in the computed tomography (CT) scanners market are Canon Medical Systems Corporation, Carestream Health, Fujifilm Corporation, GE Healthcare, General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V., Medtronic plc, Neusoft Medical Systems Co., Ltd., Planmeca Oy, Samsung Healthcare, Shenzhen Anke High-tech Co., Ltd., and Siemens Healthineers AG.

awards awards key differentiators

Reach Us

Web –

// // // //